Press Release HOME > NEWS > Press Release PharmCADD – KASBP interacted in San Diego. READ MORE Dr. Sangwook Wu, PharmCADD CTO confers Korean Prime Minister’s award for excellence in AI-based new drug development. READ MORE PharmCADD announced new AI-driven anticancer drug candidates at Drug Discovery Chemistry 2022 READ MORE AI & Quantum Physics-based technologies are reforming conventional drug development. READ MORE The evolution of AI drug development : “Generation of mRNA vaccine candidates in 24 hours” READ MORE [CEO interview] Combining AI and Quantum Mechanics to Improve Drug and Vaccine Discovery READ MORE “PharmCADD will be the 1st AI-based drug discovery company that commercializes a medicine.”, said CEO. READ MORE PharmCADD announced a licensing agreement of AI-based anti-cancer drug with REDIPHARM. READ MORE PharmCADD signed MOU with Qunova to develop new drug utilizing Quantum Computing. READ MORE « Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Next »
Dr. Sangwook Wu, PharmCADD CTO confers Korean Prime Minister’s award for excellence in AI-based new drug development. READ MORE
PharmCADD announced new AI-driven anticancer drug candidates at Drug Discovery Chemistry 2022 READ MORE
“PharmCADD will be the 1st AI-based drug discovery company that commercializes a medicine.”, said CEO. READ MORE